Wearable Photoplethysmography for Non-invasive Hydration Assessment
Condition(s) studied
Investigational drug(s) / intervention(s)
Exercise: Perform stationary cycling exercise in the laboratory for 2 30- minute bouts at a standardized exercise intensity (wattage) that elicits 50-80% heart rate max determined by equation (208-(70% of age))
Study summary
Hydration status during exercise is often determined by measuring body mass change, fluid intake and urine output. However, obtaining these measurements can be an invasive, time-consuming process. Hydration status may be detectable by analyzing blood flow patterns of the superficial (just under the skin) blood vessels. Wearable devices are now abundant among the general population, and despite attempts from several groups, a hydration status metric based on noninvasive wearable device metrics has not been developed. With wearables, a light source connected to an optical sensor transmits and reflects light through the body. The light sensor detects absorption of the light based on wavelength measurements of the detected light. Absorption of specific wavelengths of light energy is dependent upon the amount of oxygenated blood in the vessels. When the vessels expand and relax, the amount of blood volume in the observed tissue increases and decreases potentially causing a shift in the photoplethysmography (PPG) wave detected by the wearable. The shift in the shape of the PPG wave may be detected in a way that indicates the relative change in tissue hydration levels. However, to our knowledge, no wrist worn device that utilizes PPG has been successfully able to predict hydration status. Therefore, this study aims to utilize photoplethysmography (PPG) technology in a wearable device to accomplish this approach to hydration monitoring.
Eligibility
Primary outcome measure(s)
- Wearable Sensr Data — Continuous data collection over 24 hours from start of exercise trial through completion of Day 2 measurements.
photoplethysmogram (PPG) waveform data- optical signals obtained from photoplethysmography, which measure blood volume changes in the microvascular bed of tissue. - Body Mass Change — Change in body mass during 60 min exercise bout and over 24 hours from baseline
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| PepsiCo R&D | Frisco | Texas | Recruiting |
| PepsiCo R&D | Plano | Texas | Recruiting |
More PepsiCo Global R&D trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07520344 on ClinicalTrials.gov ↗ ← All trials in the USA